photo walkheader_zpsd5bunpmi.png

Monthly Archives: February 2014

Daniel Von Hoff Inducted into Lederberg Society for Work on Abraxane in Pancreatic Cancer

One of our favorite physician pancreatic cancer researchers, Daniel Von Hoff, has been honored by induction into the Joshua Lederberg Society on February 13, 2014 primarily for his work in shepherding the development of Abraxane (nab-paclitaxel) in combination with gemcitabine for the treatment of advanced cancer of the pancreas (ductal adenocarcinoma of the pancreas). This […]

Can Can for Pan Can (pancreatic cancer)

It seems pretty rare that we get humor associated with pancreatic cancer (ductal adenocarcinoma of the pancreas).  Now comes a goofy and fun awareness video piece on Youtube from a sister pancreatic cancer nonprofit organization in the UK (Pancreatic Cancer UK). Will it go viral?  Will it ignite the next new dance fad?  We can […]

MORE STROMA: Inhibiting Fibroblast Growth Factor Disrupts Pancreatic Cancer Cell Invasion

As mentioned, stromal tissue can account for as much as 90% of the bulk in pancreatic cancer tumors (ductal adenocarcinoma of the pancreas). Thought in the past to have been relatively inert, it is increasingly clear that this dense tissue arising from a desmoplastic process is surprisingly dynamic. Thus, it is heartening to encounter a […]